Naveed Sattar is Professor of Metabolic Medicine at University of Glasgow.

He has a track record of epidemiology and biomarker research in diabetes and cardiovascular disease with particular emphasis on the impact of obesity. He has also been involved in multiple cardiometabolic trials and several relevant international guidelines and is amongst the most highly cited academics in obesity and cardiometabolic conditions. He is current associate editor for Circulation and Diabetes Care.

Dr. Sattar has consulted for and/or received speaker honoraria from Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, and Sanofi; and received grant support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics.